Hamilton Company has announced multiple automation-related initiatives to aid healthcare workers and researchers as they battle the coronavirus (COVID-19) pandemic.
Two new automated assay ready workstations, based on the Company’s Microlab® STARlet liquid handling workstation, facilitate rapid, high-throughput diagnostic and research-based testing of SARS-CoV-2, the coronavirus that causes the novel COVID-19.
Both assay ready workstations are designed to work with any provider’s assay chemistry, including those intended for qualitative detection of the coronavirus. Once the coronavirus situation stabilizes, the assay ready workstations may be repurposed to provide multi-faceted efficiencies to any number of assay workflows.
The MagEx STARlet and PCR Prep STARlet add to the existing portfolio of assay ready workstations specifically designed to automate molecular biology workflows and viral testing. Other workstations in the family include the NIMBUS® Presto, which integrates the Thermo Scientific™ King Fisher™ Presto purification system for hands-free, high throughput nucleic acid extraction, and the RT STARlet, which is a walkaway solution for real-time PCR sample preparation and detection.
Finally, the Company will prioritize all incoming orders related to the fight against the coronavirus. Rapid delivery of hardware, software, accessories, and consumables is available from the Company’s manufacturing locations in Reno, Nevada, USA and Bonaduz, Switzerland. Fast-tracked order processing and delivery is meant to reduce or eliminate testing delays due to delivery lag times throughout the United States and Europe, where coronavirus testing demands are particularly high.
“Our support of the healthcare community and researchers working to identify, treat, and contain the coronavirus is our prime priority,” said Steve Hamilton, President and CEO of Hamilton Company.
Do you use Hamilton products in your lab? Write a review today for your chance to win a $400 Amazon gift card>>